Literature DB >> 12732996

Immunohistochemical evaluation for intraoperative rapid pathological assessment of the gastric margin.

Satoshi Matsusaka1, Tomohumi Nagareda, Hajime Yamasaki, Yoshihiro Kitayama, Toshihiro Okada, Shigeto Maeda.   

Abstract

In patients undergoing surgery for gastric cancer, as the resection area is difficult to define preoperatively, we define the resection area by intraoperative rapid pathological assessment of the resected margin. In some patients, however, the result of postoperative assessment of a permanent section differs from the result obtained intraoperatively. In this study we explored methods of improving the accuracy of intraoperative pathological assessment. Of the patients who underwent surgery for gastric cancer at Takarazuka Municipal Hospital, between April 2000 and July 2001, intraoperative pathological assessment of the resection margin was performed in 34 because it could not be accurately defined preoperatively. The intraoperative assessment consisted of touch smear cytological examination and hematoxylin and eosin (HE) and cytokeratin (CK) histological examination. The time required to perform cytological examination and HE and CK immunohistochemistry by this modified method, which uses an ENVISION Kit/HRP, was approximately 20 minutes for each procedure. Touch smear cytological examination gave false positive results in 3 of 34 patients (8.8%). Of the 14 patients preoperatively diagnosed with signet-ring cell carcinoma, intraoperative HE histological analysis yielded a false negative result in one (7.1%). The results of CK histological assessment of these patients were all consistent with those of postoperative examination of permanent sections. Of the 20 patients preoperatively diagnosed with non-signet-ring cell carcinoma, HE analysis yielded a false negative result in one (5%). The results of CK histological assessment of these patients were all consistent with those of postoperative examination of permanent sections. Our modified CK staining method with the ENVISION Kit/HRP allows intraoperative pathological assessment to be performed accurately and rapidly. This method is more useful than HE immunohistochemistry for the assessment of resected gastric margins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732996     DOI: 10.1007/s00268-003-6792-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma.

Authors:  F Kijima; S Natsugoe; S Takao; K Aridome; M Baba; M Yoshifumi; Y Eizuru; T Aikou
Journal:  Oncology       Date:  2000       Impact factor: 2.935

2.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

3.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

4.  Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma.

Authors:  Shoji Natsugoe; Saburo Nakashima; Masataka Matsumoto; Akihiro Nakajo; Futoshi Miyazono; Fumio Kijima; Sumiya Ishigami; Kuniaki Aridome; Shuichi Hokita; Masamichi Baba; Sonshin Takao; Takashi Aikou
Journal:  Gastric Cancer       Date:  1999-11       Impact factor: 7.370

5.  Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.

Authors:  M Mori; K Mimori; H Ueo; K Tsuji; T Shiraishi; G F Barnard; K Sugimachi; T Akiyoshi
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

Authors:  R R Turner; D W Ollila; D L Krasne; A E Giuliano
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

7.  Occult axillary lymph node metastases in "node-negative" breast carcinoma.

Authors:  I A Nasser; A K Lee; S Bosari; R Saganich; G Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1993-09       Impact factor: 3.466

8.  Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20.

Authors:  M Futamura; Y Takagi; H Koumura; H Kida; H Tanemura; K Shimokawa; S Saji
Journal:  J Surg Oncol       Date:  1998-05       Impact factor: 3.454

9.  Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies.

Authors:  J Woodcock-Mitchell; R Eichner; W G Nelson; T T Sun
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

10.  Occult axillary node metastases in breast cancer: their detection and prognostic significance.

Authors:  M A McGuckin; M C Cummings; M D Walsh; B G Hohn; I C Bennett; R G Wright
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

View more
  3 in total

1.  Intraoperative consultation (IOC) in mucosal lesions of the upper aerodigestive tract.

Authors:  Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2008-07-15

2.  Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer.

Authors:  Chang Min Lee; Ye Seob Jee; Ju-Hee Lee; Sang-Yong Son; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer.

Authors:  Doosup Shin; Sung-Soo Park
Journal:  World J Gastrointest Oncol       Date:  2013-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.